| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0.5B | $0.5B | $0.4B |
| Cost of Revenue | — | — | — | — | — | — | $0.3B | $0.2B |
| Gross Profit | — | — | — | — | — | $0.3B | $0.2B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.7B | $1.6B | $1.5B | $1.4B | $1.1B | $0.2B | $0.2B | $0.1B |
| Net Income | $1.6B | $1.4B | $1.2B | $1.1B | $0.9B | $0.2B | $0.2B | $0.1B |
| EPS (Basic) | $1.61 | $1.42 | $1.30 | $4.59 | $3.96 | $0.70 | $0.67 | $0.47 |
| EPS (Diluted) | $1.59 | $1.40 | $1.28 | $4.52 | $3.90 | $0.69 | $0.64 | $0.45 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.1B | $8.4B | $6.7B | $5.3B | $4.6B | $3.5B | $2.5B | $2.3B |
| Current Assets | $5.8B | $4.4B | $3.3B | $2.2B | $1.7B | $1.0B | $0.7B | $0.7B |
| Cash & Equivalents | — | — | — | — | — | — | $0.2B | $0.3B |
| Total Liabilities | $0.9B | $0.9B | $0.8B | $0.7B | $1.0B | $1.0B | $0.8B | $0.7B |
| Current Liabilities | $0.7B | $0.6B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B |
| Stockholders' Equity | — | — | $6.0B | $4.6B | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.5B | $1.4B | $1.2B | $1.0B | $0.9B | $0.6B | — |
| Investing Cash Flow | $-0.6B | $-0.9B | $-1.9B | $-0.4B | $-0.5B | $-0.6B | $-0.4B | — |
| Capital Expenditures | $0.6B | $0.5B | $0.5B | $0.3B | $0.5B | $0.6B | $0.4B | $0.3B |
| Financing Cash Flow | $0.1B | $0.0B | $0.1B | $-0.4B | $0.0B | $-0.0B | $-0.4B | — |